Cellect Biotechnology Stock Forecast, Price & News

-0.12 (-3.80 %)
(As of 06/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume63,993 shs
Average Volume352,284 shs
Market Capitalization$6.81 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive APOP News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Cellect Biotechnology logo

About Cellect Biotechnology

Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was incorporated in 1986 and is headquartered in Kfar Saba, Israel.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.56 out of 5 stars

Medical Sector

1507th out of 2,099 stocks

Surgical & Medical Instruments Industry

137th out of 174 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cellect Biotechnology (NASDAQ:APOP) Frequently Asked Questions

What stocks does MarketBeat like better than Cellect Biotechnology?

Wall Street analysts have given Cellect Biotechnology a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cellect Biotechnology wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cellect Biotechnology's next earnings date?

Cellect Biotechnology is scheduled to release its next quarterly earnings announcement on Thursday, June 17th 2021.
View our earnings forecast for Cellect Biotechnology

How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) issued its earnings results on Monday, March, 29th. The company reported ($0.39) EPS for the quarter.
View Cellect Biotechnology's earnings history

How has Cellect Biotechnology's stock price been impacted by Coronavirus?

Cellect Biotechnology's stock was trading at $1.71 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APOP shares have increased by 77.8% and is now trading at $3.04.
View which stocks have been most impacted by COVID-19

Who are Cellect Biotechnology's key executives?

Cellect Biotechnology's management team includes the following people:
  • Dr. Shai Yarkoni, Co-Founder, CEO & Director (Age 63)
  • Mr. Eyal Leibovitz, Chief Financial Officer (Age 60)
  • Dr. Amos Ofer, Chief Operating Officer (Age 45)
  • Dr. Yael Kenan, VP of Clinical Affairs (Age 58)

Who are some of Cellect Biotechnology's key competitors?

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

What is Cellect Biotechnology's stock symbol?

Cellect Biotechnology trades on the NASDAQ under the ticker symbol "APOP."

Who are Cellect Biotechnology's major shareholders?

Cellect Biotechnology's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.95%), HRT Financial LP (0.93%), Virtu Financial LLC (0.91%), Citadel Advisors LLC (0.73%) and Citadel Advisors LLC (0.73%).

Which institutional investors are selling Cellect Biotechnology stock?

APOP stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

Which institutional investors are buying Cellect Biotechnology stock?

APOP stock was acquired by a variety of institutional investors in the last quarter, including HRT Financial LP, Virtu Financial LLC, Citadel Advisors LLC, and Citadel Advisors LLC.

How do I buy shares of Cellect Biotechnology?

Shares of APOP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cellect Biotechnology's stock price today?

One share of APOP stock can currently be purchased for approximately $3.04.

How much money does Cellect Biotechnology make?

Cellect Biotechnology has a market capitalization of $6.81 million.

How many employees does Cellect Biotechnology have?

Cellect Biotechnology employs 12 workers across the globe.

What is Cellect Biotechnology's official website?

The official website for Cellect Biotechnology is

Where are Cellect Biotechnology's headquarters?

Cellect Biotechnology is headquartered at 23 HATA`AS STREET, KFAR SABA L3, 44425.

How can I contact Cellect Biotechnology?

Cellect Biotechnology's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The company can be reached via phone at 972-9974-1444 or via email at [email protected]

This page was last updated on 6/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.